hematological malignanciesmissed diagnosismedicinepharmacologycancer carehematologyclinical pharmacyoncologyinfectious diseasespharmaceutical practice
A Phase II Study of Pegylated-Camptothecin (Pegamotecan) in the Treatment of Locally Advanced and Metastatic Gastric and Gastro-Oesophageal Junction and Adenocarcinoma. Cancer Chemother Pharmacol (2009)
metastasispharmacologyfuture medicinal chemistrygastrointestinal surgerymetastatic gastricanti-cancer agentsphase ii studyoncologygastroenterologygastrointestinal oncologypathologygastro-oesophageal junction
Linda T. VahdatBrian PruittCarol J. FabianRagene R. RiveraDavid A. SmithElizabeth Tan-ChiuJonathan WrightAntoinette R. TanNoshir A. DaCostaEllen ChuangJohn SmithJoyce O'ShaughnessyDale E. ShusterNicole L. MenesesKumari ChandrawansaFang FangPatricia E. ColeSimon AshworthJoanne L. Blum
immunologyneurologypharmacologycancer carecancer researchanti-cancer agentsphase ii studydrug discoverybreast canceroncologyclinical researchmedicinal researchcancer treatmenteribulin mesylatemetastatic breast cancer